Clinical Trial Update: A Single Dose Study of SHR4640 in Healthy Male Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 single-dose study of SHR4640 in healthy male volunteers has completed. The sponsor is Atridia Pty Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• SHR4640

Snippet

Sponsor: Atridia Pty Ltd. | Conditions: Gout | Phase 1 | Status: COMPLETED